Staff
Head: | Prof. Gerd Mikus, MD, MSc |
Scientific staff: | Antje Blank, MD Verena Hafner, MD Sonja König, Doctor Christoph Markert, MD |
Visiting scientist: | Sybille Baumann, MD |
Study assistant: | Marlies Stützle-Schnetz |
Study nurse: | Brigitte Tayrouz |
Doctoral students: | Stephanie Katzenmaier Ines Fuchs Ulrike Merkel Isabel Wustrow Victoria Ziesenitz |
- K084: Pharmacokinetics of intravenous voriconazole and its excipient SBECD in patients receiving haemodialysis, haemodiafiltration, or Genius-dialysis (multicenter).
- K093: Genotype screening of volunteers for the participation in clinical studies.
- K106: AOP101 (first in man study) (Cooperation with Innere Medizin V).
- K119: Evaluation and validation of a 5-drug cocktail for phenotyping of CYP1A2, CYP2C9, CYP2C19. CYP2D6, CYP3A4, NAT-2, and xanthine oxidase.
- K171: Enterohepatic circulation of THCCOOH (Cooperation with Institute of Legal Medicine).
- K145: Pharmacodynamic interaction of a novel NO independent activator of sGC and glyceroltrinitrate.
- K155: Monocenter, open study on the pharmacokinetics of efavirenz: Assessment of induction of CYP3A4 and CYP2B6 as well as auto-inductive effects.
- 12 beds
- 2 out-patient rooms
- dayroom for test persons / patients
- Mortara monitoring system at each bed connected to a central processing and reviewing unit
- 12-lead ECG
- non-invasive blood pressure measurements
- pO2 measurements
- invasive blood pressure monitoring (3 beds)
- hand vein compliance measuring technique
- cold-pressure-test
- laser-doppler-flow
- establishment, validation and application of new phenotyping models
- rooms for sample processing, drug storage, sample storage
- RNA-extraction
- reanimation team
- volunteer database
- Standard Operation Procedures (SOPs) for equipment and activities
- Database system for managing personal data of test persons, generating codes for samples, and printing their labels
- Study Builder software
- pharmacokinetic analysis with WinNonlin (Pharsight)
- MEMS™ Compliance-Monitoring
- Drug storage facilities at +4°C and +18°C
- Sample storage facilities at -20°C or -80°C
Products / Services
- Preparation of investigation schedules and CRFs
- Organisation of Phase I-II trials, bioequivalence trials, pharmacokinetic and pharmacodynamic analyses
- Preparation of final reports
Cooperations